These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 25641469)

  • 61. Acute and late complications after radiotherapy for prostate cancer: results of a multicenter randomized trial comparing 68 Gy to 78 Gy.
    Peeters ST; Heemsbergen WD; van Putten WL; Slot A; Tabak H; Mens JW; Lebesque JV; Koper PC
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1019-34. PubMed ID: 15752881
    [TBL] [Abstract][Full Text] [Related]  

  • 62. UroLift as a surrogate for fiducial markers in IGRT planning of prostate cancer in BPH patients.
    Biswal NC; Swann B; McKenna MG; Singh R
    Pract Radiat Oncol; 2018; 8(4):e231-e233. PubMed ID: 29452872
    [No Abstract]   [Full Text] [Related]  

  • 63. Implantation of fiducial markers for image guidance in prostate radiotherapy: patient-reported toxicity.
    Igdem S; Akpinar H; Alço G; Agaçayak F; Turkan S; Okkan S
    Br J Radiol; 2009 Nov; 82(983):941-5. PubMed ID: 19505970
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A review of the use of fiducial markers for image-guided bladder radiotherapy.
    Nolan CP; Forde EJ
    Acta Oncol; 2016 May; 55(5):533-8. PubMed ID: 26588169
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effects of gold fiducial marker implantation on tumor control and toxicity in external beam radiotherapy of prostate cancer.
    Moll M; Weiß M; Stanisav V; Zaharie A; Goldner G
    Radiol Oncol; 2023 Mar; 57(1):95-102. PubMed ID: 36653352
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Dosimetric impact and theoretical clinical benefits of fiducial markers for dose escalated prostate cancer radiation treatment.
    Gauthier I; Carrier JF; Béliveau-Nadeau D; Fortin B; Taussky D
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1128-33. PubMed ID: 19147306
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Critical evaluation of magnetic resonance imaging targeted, transrectal ultrasound guided transperineal fusion biopsy for detection of prostate cancer.
    Kuru TH; Roethke MC; Seidenader J; Simpfendörfer T; Boxler S; Alammar K; Rieker P; Popeneciu VI; Roth W; Pahernik S; Schlemmer HP; Hohenfellner M; Hadaschik BA
    J Urol; 2013 Oct; 190(4):1380-6. PubMed ID: 23608676
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Assessment of prostatic fiducial marker introduction: patient morbidity, staff satisfaction and improved treatment field placement.
    Brown S; Lehman M; Ferrari-Anderson J; Glyde A; Burmeister E; Nicol D
    J Med Imaging Radiat Oncol; 2011 Aug; 55(4):417-24. PubMed ID: 21843178
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Ultrasound-Guided Placement of Gold Fiducial Markers for Stereotactic Partial-Breast Irradiation.
    Seiler S; Rahimi A; Choudhery S; Garwood D; Spangler A; Cherian S; Goudreau S
    AJR Am J Roentgenol; 2016 Sep; 207(3):685-8. PubMed ID: 27505612
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Potential position errors using fiducial markers for gated image guided radiotherapy.
    Nielsen MS; Nyström MW; Carl J
    Acta Oncol; 2013 Oct; 52(7):1472-6. PubMed ID: 23984813
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Radiotherapy for prostate cancer: Effect of gold fiducial markers on diffusion-weighted magnetic resonance imaging.
    Tanaka O; Maejima R; Yama E; Taniguchi T; Ono K; Makita C; Matsuo M
    Asia Pac J Clin Oncol; 2021 Feb; 17(1):79-83. PubMed ID: 32969171
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Dosimetric effects of the prone and supine positions on image guided localized prostate cancer radiotherapy.
    Liu B; Lerma FA; Patel S; Amin P; Feng Y; Yi BY; Yu C
    Radiother Oncol; 2008 Jul; 88(1):67-76. PubMed ID: 18207595
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Interfraction rotation of the prostate as evaluated by kilovoltage X-ray fiducial marker imaging in intensity-modulated radiotherapy of localized prostate cancer.
    Graf R; Boehmer D; Budach V; Wust P
    Med Dosim; 2012; 37(4):396-400. PubMed ID: 22534137
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Targeted Antibiotic Prophylaxis for Transrectal Fiducial Marker Insertion for Prostate Radiotherapy.
    Henderson DR; Murray JR; Tree AC; Riley U; Rosenfelder NA; Murray D; Khoo VS; van As NJ
    Clin Oncol (R Coll Radiol); 2016 Mar; 28(3):226-7. PubMed ID: 26447001
    [No Abstract]   [Full Text] [Related]  

  • 75. Phase II study of hypofractionated image-guided radiotherapy for localized prostate cancer: outcomes of 55 Gy in 16 fractions at 3.4 Gy per fraction.
    Wu JS; Brasher PM; El-Gayed A; Pervez N; Tai PT; Robinson J; Skarsgard D; Joseph K; Sia MA; Pearcey RG
    Radiother Oncol; 2012 May; 103(2):210-6. PubMed ID: 22280805
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Adaptive radiotherapy for prostate cancer using kilovoltage cone-beam computed tomography: first clinical results.
    Nijkamp J; Pos FJ; Nuver TT; de Jong R; Remeijer P; Sonke JJ; Lebesque JV
    Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):75-82. PubMed ID: 17869445
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Technique for implantation of fiducial markers in the prostate.
    Shinohara K; Roach M
    Urology; 2008 Feb; 71(2):196-200. PubMed ID: 18308082
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Improving positioning in high-dose radiotherapy for prostate cancer: safety and visibility of frequently used gold fiducial markers.
    Fonteyne V; Ost P; Villeirs G; Oosterlinck W; Impens A; De Gersem W; De Wagter C; De Meerleer G
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):46-52. PubMed ID: 22014956
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The contribution of on-line correction for rotational organ motion in image-guided radiotherapy of the bladder and prostate.
    Redpath AT; Wright P; Muren LP
    Acta Oncol; 2008; 47(7):1367-72. PubMed ID: 18661436
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Safety and efficacy of MRI-guided transurethral ultrasound ablation for radiorecurrent prostate cancer in the presence of gold fiducial markers.
    Mäkelä P; Wright C; Anttinen M; Boström PJ; Blanco Sequeiros R
    Acta Radiol; 2023 Mar; 64(3):1228-1237. PubMed ID: 35748746
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.